Clinically validated approaches to the treatment of autoimmune diseases
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Clinically validated approaches to the treatment of autoimmune diseases
Authors
Keywords
-
Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 19, Issue 2, Pages 195-213
Publisher
Informa Healthcare
Online
2010-01-06
DOI
10.1517/13543780903418452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Infliximab and Etanercept Are Equally Effective in Reducing Enterocyte APOPTOSIS in Experimental Colitis
- (2012) Walter Fries et al. International Journal of Medical Sciences
- Neutralization of interferon-α/β-inducible genes and downstream effect in a phase I trial of an anti-interferon-α monoclonal antibody in systemic lupus erythematosus
- (2009) Yihong Yao et al. ARTHRITIS AND RHEUMATISM
- Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis
- (2009) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Rituximab and lupus: Good in real life, bad in controlled trials. comment on the article by Lu et al
- (2009) Manuel Ramos-Casals et al. ARTHRITIS AND RHEUMATISM
- Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: Results of two randomized, double-blind, placebo-controlled clinical studies
- (2009) Nemanja Damjanov et al. ARTHRITIS AND RHEUMATISM
- The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double-blind, placebo-controlled phase IIa trial of three dosage levels of CP-690,550 versus placebo
- (2009) Joel M. Kremer et al. ARTHRITIS AND RHEUMATISM
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Novel evidence-based systemic lupus erythematosus responder index
- (2009) Richard A. Furie et al. ARTHRITIS AND RHEUMATISM
- Rediscovering alemtuzumab: current and emerging therapeutic roles
- (2009) John G. Gribben et al. BRITISH JOURNAL OF HAEMATOLOGY
- Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor
- (2009) Zehra Kaymakcalan et al. CLINICAL IMMUNOLOGY
- Safety Assessment and Dose Selection for First-in-Human Clinical Trials With Immunomodulatory Monoclonal Antibodies
- (2009) PY Muller et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Pathogenic agents in inflammatory bowel diseases
- (2009) Guillaume Pineton de Chambrun et al. CURRENT OPINION IN GASTROENTEROLOGY
- B cell depletion in lupus and Sjögrenʼs syndrome: an update
- (2009) Andreea Coca et al. CURRENT OPINION IN RHEUMATOLOGY
- Why can't we find a new treatment for SLE?
- (2009) Robert Eisenberg JOURNAL OF AUTOIMMUNITY
- Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
- (2009) G. B. Appel et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
- (2009) Josef S Smolen et al. LANCET
- Immunology's quiet upheaval
- (2009) Ken Garber NATURE BIOTECHNOLOGY
- Golimumab
- (2009) Dimitrios A. Pappas et al. NATURE REVIEWS DRUG DISCOVERY
- Rheumatoid arthritis market
- (2009) Jeffrey G. Stoll et al. NATURE REVIEWS DRUG DISCOVERY
- Targeted therapy for psoriatic arthritis
- (2009) Dafna D. Gladman Nature Reviews Rheumatology
- What does the death of Riquent™ hold for the future of SLE?
- (2009) Joan T. Merrill et al. Nature Reviews Rheumatology
- Oral fingolimod (FTY720) in multiple sclerosis: Two-year results of a phase II extension study
- (2009) P. O'Connor et al. NEUROLOGY
- Molecular therapies for systemic lupus erythematosus: clinical trials and future prospects
- (2009) Fanny Monneaux et al. ARTHRITIS RESEARCH & THERAPY
- Role of Inflammation in Atherosclerosis Associated with Rheumatoid Arthritis
- (2008) Peter Libby AMERICAN JOURNAL OF MEDICINE
- Safety and Efficacy of ABT-874, a Fully Human Interleukin 12/23 Monoclonal Antibody, in the Treatment of Moderate to Severe Chronic Plaque Psoriasis
- (2008) Alexa B. Kimball ARCHIVES OF DERMATOLOGY
- Treatment of rheumatoid arthritis with a syk kinase inhibitor: A twelve-week, randomized, placebo-controlled trial
- (2008) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial
- (2008) Mario H. Cardiel et al. ARTHRITIS AND RHEUMATISM
- Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
- (2008) Edward Keystone et al. ARTHRITIS AND RHEUMATISM
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study
- (2008) Jonathan Kay et al. ARTHRITIS AND RHEUMATISM
- The incidence of autoimmune thyroid disease: a systematic review of the literature
- (2008) Anita McGrogan et al. CLINICAL ENDOCRINOLOGY
- Abatacept: a T-cell co-stimulation modulator for the treatment of rheumatoid arthritis
- (2008) Andrew J K Östör CLINICAL RHEUMATOLOGY
- Multiple sclerosis: new treatment trials and emerging therapeutic targets
- (2008) Tracy DeAngelis et al. CURRENT OPINION IN NEUROLOGY
- Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus
- (2008) Martin Aringer et al. Expert Opinion On Drug Safety
- Emerging oral drugs for multiple sclerosis
- (2008) Claudio Gasperini et al. EXPERT OPINION ON EMERGING DRUGS
- Kinase inhibitors as drugs for chronic inflammatory and immunological diseases: progress and challenges
- (2008) Laura L Rokosz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease
- (2008) William J. Sandborn et al. GASTROENTEROLOGY
- CD28 Superagonists: What Makes the Difference in Humans?
- (2008) Burkhart Schraven et al. IMMUNITY
- Interferon Alpha-Induced Lupus
- (2008) Timothy B. Niewold JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases
- (2008) Eric J. Boren et al. JOURNAL OF AUTOIMMUNITY
- The calm after the cytokine storm: lessons from the TGN1412 trial
- (2008) E. William St. Clair JOURNAL OF CLINICAL INVESTIGATION
- Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis
- (2008) C. L. Hirst et al. JOURNAL OF NEUROLOGY
- Glatiramer Acetate
- (2008) François Blanchette et al. JOURNAL OF NEUROLOGY
- Efficacy of ISA247 in plaque psoriasis: a randomised, multicentre, double-blind, placebo-controlled phase III study
- (2008) K Papp et al. LANCET
- Crohn's disease: beyond antagonists of tumour necrosis factor
- (2008) Laurent Peyrin-Biroulet et al. LANCET
- Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study
- (2008) Benjamin M Segal et al. LANCET NEUROLOGY
- Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci
- (2008) John B Harley et al. NATURE GENETICS
- Novel therapeutic strategies for multiple sclerosis — a multifaceted adversary
- (2008) Rocio S. Lopez-Diego et al. NATURE REVIEWS DRUG DISCOVERY
- Multiple Lessons for Multiple Sclerosis
- (2008) Stephen L. Hauser NEW ENGLAND JOURNAL OF MEDICINE
- Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
- Systemic Lupus Erythematosus
- (2008) Anisur Rahman et al. NEW ENGLAND JOURNAL OF MEDICINE
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of etanercept in rheumatoid arthritis
- (2008) Maria I Danila et al. PHARMACOGENOMICS
- Medical management of Crohn’s disease
- (2008) J R Fraser Cummings et al. BMJ-British Medical Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More